Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis

AbstractThe aim of the study was to report the clinical, biological, and pathological characteristics of patients with glomerulonephritis (GN) secondary to systemic lupus erythematosus (SLE)/antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) overlap syndrome.A nationwide survey was conducted to identify cases of SLE/AAV overlap syndrome. Data were collected from SLE and AAV French research groups. Inclusion criteria were diagnosis of both SLE and AAV according to international classification criteria and biopsy-proven GN between 1995 and 2014. Additional cases were identified through a systematic literature review. A cohort of consecutive biopsy-proven GN was used to study the prevalence of overlapping antibodies and/or overlap syndrome.The national survey identified 8 cases of SLE/AAV overlap syndrome. All patients were female; median age was 40 years. AAV occurred before SLE (n = 3), after (n = 3), or concomitantly (n = 2). Six patients had rapidly progressive GN and 3/8 had alveolar hemorrhage. All patients had antinuclear antibodies (ANA); 7/8 had p-ANCA antimyeloperoxidase (MPO) antibodies. Renal biopsies showed lupus nephritis (LN) or pauci-immune GN. Remission was obtained in 4/8 patients. A literature review identified 31 additional cases with a similarly severe presentation. In the GN cohort, ANCA positivity was found in 30% of LN, ANA positivity in 52% of pauci-immune GN, with no correlation with pathological findings. The estimated prevalence for SLE/AAV overlap syndrome was 2/101 (2%).In patients with GN, SLE/AAV overlap syndrome may occur but with a low prevalence. Most patients have an aggressive renal presentation, with usually both ANA and anti-MPO antibodies. Further studies are needed to assess shared pathogenesis and therapeutic options.

[1]  D. Metze,et al.  Nomenclature of cutaneous vasculitides – German translation of the dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides , 2018, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[2]  J. Pers,et al.  ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review. , 2015, Autoimmunity reviews.

[3]  L. MaroñasJiménez,et al.  Systemic lupus erythematosus , 2014 .

[4]  R. Falk,et al.  Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease , 2014, Nature Reviews Rheumatology.

[5]  Virginia Pascual,et al.  Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures , 2014, Arthritis & rheumatology.

[6]  M. Mayr,et al.  Rapidly Progressive Lupus Nephritis with Extremely High Levels of Antineutrophil Cytoplasmic Antibodies , 2014, Case Reports in Nephrology and Dialysis.

[7]  M. Segal,et al.  Lupus Nephritis and End-stage Kidney Disease , 2013, The American journal of the medical sciences.

[8]  P. Heeringa,et al.  Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. , 2013, The Journal of clinical investigation.

[9]  L. Mouthon,et al.  Systemic Vasculitis During the Course of Systemic Sclerosis , 2013, Medicine.

[10]  Z. Amoura,et al.  Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome? , 2012, Rheumatology International.

[11]  Matthias Kretzler,et al.  Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus , 2011, The Journal of Immunology.

[12]  M. Isono,et al.  Diffuse alveolar hemorrhage in lupus nephritis complicated by microscopic polyangiitis , 2011, Clinical and Experimental Nephrology.

[13]  P. Villiger,et al.  Microscopic polyangiitis: Clinical presentation. , 2010, Autoimmunity reviews.

[14]  Irmgard Neumann,et al.  Histopathologic classification of ANCA-associated glomerulonephritis. , 2010, Journal of the American Society of Nephrology : JASN.

[15]  D. Goldsmith,et al.  Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe , 2010, International Urology and Nephrology.

[16]  Su-xia Wang,et al.  Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. , 2009, Kidney international.

[17]  Z. Werb,et al.  Netting neutrophils in autoimmune small-vessel vasculitis , 2009, Nature Medicine.

[18]  F. Vivino,et al.  Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis , 2009, Modern rheumatology.

[19]  David Steven Scott,et al.  Modification and validation of the Birmingham Vasculitis Activity Score (version 3) , 2008, Annals of the rheumatic diseases.

[20]  N. Knowlton,et al.  Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures. , 2008, Arthritis and rheumatism.

[21]  T. Akizawa,et al.  Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia , 2008, Clinical and Experimental Nephrology.

[22]  V. D’Agati,et al.  Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[23]  R. Quigg,et al.  Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti-neutrophil cytoplasmic antibodies. , 2007, Kidney international.

[24]  M. Ramos-Casals,et al.  The overlap of Sjögren's syndrome with other systemic autoimmune diseases. , 2007, Seminars in arthritis and rheumatism.

[25]  R. Caporali,et al.  Clinical features of ANCA‐positive systemic lupus erythematosus: report of two cases , 2007, Scandinavian journal of rheumatology.

[26]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[27]  R. Cervera,et al.  Vasculitis in Systemic Lupus Erythematosus: Prevalence and Clinical Characteristics in 670 Patients , 2006, Medicine.

[28]  F. E. Van den Bosch,et al.  The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications , 2005, Lupus.

[29]  J. Bariéty,et al.  Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. , 2005, Kidney international.

[30]  M. Haas,et al.  Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. , 2004, Kidney international.

[31]  E. Serdaroğlu,et al.  Is ACE gene polymorphism a risk factor for renal scarring with low-grade reflux? , 2004, Pediatric Nephrology.

[32]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[33]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[34]  N. Kiper,et al.  A boy with consecutive development of SLE and Wegener granulomatosis , 2004, Pediatric Nephrology.

[35]  G. Hughes,et al.  Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients , 2003, Medicine.

[36]  D. Isenberg,et al.  Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus , 2003, Lupus.

[37]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[38]  I. Neumann,et al.  Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  S. Miller,et al.  Epitope spreading in immune-mediated diseases: implications for immunotherapy , 2002, Nature Reviews Immunology.

[40]  Joni K. Evans,et al.  Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. , 2001, Kidney international.

[41]  G. Hughes,et al.  Systemic lupus erythematosus , 2001, The Lancet.

[42]  C. Ahn,et al.  Clinical Implications of Antineutrophil Cytoplasmic Antibody Test in Lupus Nephritis , 2000, American Journal of Nephrology.

[43]  J. Piette,et al.  Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: Prevalence, clinical associations and correlation with other autoantibodies , 1998 .

[44]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[45]  R. Bernstein,et al.  Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. , 1994, British journal of rheumatology.

[46]  C. Li,et al.  Antilactoferrin antibody in systemic lupus erythematosus. , 1992, British journal of rheumatology.

[47]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[48]  W. Chak,et al.  Distinction between antinuclear antibody and P-ANCA. , 1991, Journal of clinical pathology.

[49]  E. Lewis,et al.  Necrotizing glomerulitis of systemic lupus erythematosus. , 1983, Human pathology.

[50]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[51]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[52]  A. Zhernakova,et al.  Detecting shared pathogenesis from the shared genetics of immune-related diseases , 2009, Nature Reviews Genetics.

[53]  S. Inokuma,et al.  Intrapulmonary hemorrhage in collagen-vascular diseases includes a spectrum of underlying conditions. , 2009, Internal medicine.

[54]  A. Hida,et al.  Successful Treatment of Rapidly Progressive Lupus Nephritis Associated with Anti-MPO Antibodies by Intravenous Immunoglobulins , 1999, Clinical Rheumatology.

[55]  J. Piette,et al.  Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE. , 1998, Clinical and experimental rheumatology.